#Covid19 report: $REGN and $SNY arthritis drug #Kevzara shows mixed effect in #coronavirus treatment, while a report out of Japan says the country is gearing up to approve $GILD's #remdesivir. #stocks #biotech #pharmaceuticals #investingnews https://t.co/sHPAWGRzTe